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Abstract
Porphyromonas gingivalis is a Gram-negative oral anaerobe that is involved in
the pathogenesis of periodontitis, an inflammatory disease that destroys the
tissues supporting the tooth, eventually leading to tooth loss. Porphyromonas
gingivalis has can locally invade periodontal tissues and evade the host defence
mechanisms. In doing so, it utilizes a panel of virulence factors that cause
deregulation of the innate immune and inflammatory responses. The present
review discusses the invasive and evasive strategies of P. gingivalis and the role
of its major virulence factors in these, namely lipopolysaccharide, capsule,
gingipains and fimbriae. Moreover, the role of P. gingivalis as a ‘keystone’
biofilm species in orchestrating a host response, is highlighted.
Introduction
Porphyromonas gingivalis and association with
periodontal disease
Periodontal disease, or periodontitis, is defined as a
bacterially induced inflammatory disease of the tooth-
supporting (periodontal) tissues. Although more than 700
bacterial species can colonize the oral cavity (Aas et al.,
2005), only a handful of those are highly implicated in
the disease (Paster et al., 2006). Porphyromonas gingivalis
is the species most highly associated with the chronic
form of periodontitis, and can be detected in up to 85%
of the disease sites (Yang et al., 2004). It is detected rarely
or at low in numbers in healthy sites. The presence of
P. gingivalis in a periodontal pocket may predict immi-
nent disease progression (van Winkelhoff et al., 2002)
and a significant positive correlation is found between
P. gingivalis numbers and pocket depth (Kawada et al.,
2004). Following periodontal treatment, a reduction of
P. gingivalis numbers is associated with resolution of
disease at the affected site (Haffajee et al., 1997; Fujise
et al., 2002). Moreover, experimental implantation of
P. gingivalis in animal models induces an inflammatory
response and periodontal bone loss (Evans et al., 1992;
Hajishengallis et al., 2011). This species possesses a
number of potential virulence factors, such as cysteine
proteinases (gingipains), lipopolysaccharide (LPS), capsule
and fimbriae (Lamont & Jenkinson, 1998). Collectively,
due to these properties P. gingivalis is considered an
‘opportunistic pathogen’, in line with the modified Koch’s
postulates for oral infections, such as periodontal diseases
(Socransky, 1979).
Structural and growth characteristics of
P. gingivalis
Porphyromonas gingivalis is a black-pigmented, assacchar-
olytic, non-motile Gram-negative species that requires
anaerobic conditions for growth, and the presence of
heme or hemin and vitamin K in its nutrient milieu. It
gains its metabolic energy by fermenting amino acids, a
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property decisive for its survival in deep periodontal
pockets, where sugars are extremely scarce. When consid-
ering its location in multispecies subgingival biofilm com-
munities, P. gingivalis is a late colonizer, and hence is
found in close proximity to and interacts with the juxta-
posing gingival tissue (Kolenbrander et al., 2011; Zijnge
et al., 2011). The black pigmentation of P. gingivalis colo-
nies observed in blood agar culture is itself associated
with the aggregation of heme on its cell surface (Liu
et al., 2004; Smalley et al., 2006). This property is some-
how connected to its capacity to act as an opportunistic
pathogen, as when grown in a heme-limited medium it
becomes less virulent (McKee et al., 1986).
Invasion of the host by P. gingivalis
As part of its strategies for survival into the host, P. gingi-
valis is able to invade cells and tissues (Yilmaz, 2008),
thus avoiding the immune surveillance. Porphyromonas
gingivalis can actively invade gingival epithelial cells,
where it can maintain viability and replicate (Belton
et al., 1999; Tribble et al., 2006). This invasive property is
dependent on its major fimbriae, which bind to b1 inte-
grin on the surface of host cells, an event that causes
rearrangements of the actin cytoskeleton to allow inter-
nalization (Yilmaz et al., 2002, 2003). Porphyromonas gin-
givalis can also invade macrophages, but within these cells
its replication is less active (Wang et al., 2007). This is
potentially a strategy for limited exposure to the extracel-
lular environment and evasion of the immune surveil-
lance. Interestingly, once P. gingivalis has invaded
intracellularly, there are no signs of apoptosis or necrosis
(Nakhjiri et al., 2001). It can then actively secrete an
ATP-hydrolysing enzyme, thus suppressing ATP-
dependent apoptosis (Yilmaz et al., 2008) and allowing its
survival in host cells. Subsequently, it can disseminate
from cell to cell, through actin cytoskeleton bridges with-
out causing cell death, and spread while avoiding
immune surveillance (Yilmaz et al., 2006). Once P. gingi-
valis is established in the cell, it affects cell-cycle pathways
and thus accelerates proliferation of gingival epithelial
cells, in a fimbriae-dependent fashion (Kuboniwa et al.,
2008). This could well constitute a mechanism of expan-
sion of the periodontal pocket epithelium, which is a his-
topathological feature of periodontitis.
Survival strategies of P. gingivalis
It is now well established that P. gingivalis is not an
aggressor of the inflammatory response, but rather an
opportunist that can cross-talk with the host and subvert
its defence mechanisms. Using this strategy, P. gingivalis
prolongs its survival and becomes established in the
periodontal pocket (Hajishengallis et al., 2011). It prefer-
entially deregulates innate immunity, which may in turn
disable adaptive immunity (Hajishengallis, 2009; Pathir-
ana et al., 2010). Important representative examples of
these abilities are its capacity to degrade human defensins
(Carlisle et al., 2009), its resistance to oxidative burst-
killing by polymorphonuclear neutrophils (PMNs) (Mydel
et al., 2006) and its ability to inhibit ‘at will’ the produc-
tion of crucial proinflammatory cytokines (Bostanci et al.,
2007a, b). Although P. gingivalis has the capacity to stim-
ulate interleukin (IL)-8 production by epithelial cells
(Sandros et al., 2000; Asai et al., 2001; Kusumoto et al.,
2004), it can also inhibit IL-8 production, resulting in
hindered PMN chemotaxis, a phenomenon known as
‘chemokine paralysis’ (Darveau et al., 1998). Porphyro-
monas gingivalis thereby incapacitates the first line of
defence in the periodontal tissues. Moreover, by inhibit-
ing IL-12 production by macrophages, it prevents cyto-
toxic T-cell activation and therefore bacterial clearance
(Hajishengallis et al., 2007). Accordingly, by inhibiting
interferon (IFN)-c production by T cells, it inhibits mac-
rophage bacteriocidal activity and hence bacterial clear-
ance (Pulendran et al., 2001; Hajishengallis et al., 2007).
A special relationship is also revealed between P. gingiva-
lis and the complement system, as it can suppress its acti-
vation, that is by degradation of C3 and capturing of
C4b-binging protein, but also by synergizing with C5a via
exploiting toll-like receptor (TLR)-2 signalling (Wang
et al., 2010). A further interesting point is that whole
viable P. gingivalis is differentially sensed by the host,
compared with its released virulence factors, with the
potential to activate distinctive intracellular pathways
(Pathirana et al., 2010), or differential cytokine produc-
tion (Zhou et al., 2005).
Virulence factors of P. gingivalis
As an opportunistic pathogen, it is not surprising that
P. gingivalis possesses a number of virulence factors.
These are molecules that can elicit deleterious effects on
host cells, essentially the survival ‘weapons’ of P. gingiva-
lis. The main virulence factors discussed here are LPS,
capsular polysaccharide (CPS), fimbriae and gingipains.
The LPS of P. gingivalis
Like all Gram-negative bacterial species, P. gingivalis is
sheathed by an LPS, which is an outer membrane compo-
nent recognized by the host that can trigger intracellular
signalling events. The affinity of LPS to its pattern recog-
nition receptors, such as the TLRs and CD14, enables dis-
crimination between commensal and pathogenic species.
The P. gingivalis LPS is a stimulator of proinflammatory
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responses and bone resorption, as demonstrated in exper-
imental animal models (Chiang et al., 1999; Nishida
et al., 2001). In vitro, it stimulates proinflammatory cyto-
kine production of, for example, IL-1a, IL-1b, IL-6, IL-8,
IL-18 and tumour necrosis factor (TNF)-a in monocytes
(Zhou et al., 2005; Bostanci et al., 2007a, b; Hamedi
et al., 2009). Yet, P. gingvalis LPS exhibits controversial
features with regard to the induction of an inflammatory
response. Apart from being a weaker cytokine stimulator
compared with the LPS of other Gram-negative (i.e.
enteropathogenic) species (Liu et al., 2008), it can also
antagonize the cytokine-stimulating capacity of other
putative pathogens (Bostanci et al., 2007a, b).
Structurally, P. gingivalis LPS exhibits unique features
compared with the LPS of other species. These include
differences in the structure of the O-antigen between
P. gingivalis strains that can confer antigenic differences
(Paramonov et al., 2001, 2009), as well as in the acylation
patterns and receptor-activating capacities of the lipid A
component. While the lipid A of most Gram-negative
species is a strong activator of TLR4 responses, P. gingiva-
lis lipid A is predominantly a TLR2 activator and may
even act as antagonist to TLR4 (Darveau et al., 2004),
dampening the immune responses (Hajishengallis, 2009).
When considering further the heterogeneous acylation
patterns of P. gingivalis lipid A, two forms are predomi-
nant: the tetra-acylated and penta-acylated forms. These
two structures induce opposing host responses. The
penta-acylated lipid A activates TLR4, whereas tetra-acyl-
ated lipid A acts as a TLR4 antagonist (Darveau et al.,
2004; Nemoto et al., 2006). These changes of P. gingivalis
lipid A acylation are dependent on microenvironmental
conditions. In particular, when hemin availability is high
(a condition that reflects inflammation), penta-acylated
lipid A is converted into tetra-acylated lipid A (Al-Qutub
et al., 2006). Hence, by modifying its lipid A structure
according to the microenvironment, P. gingivalis may
modulate the binding affinity of its LPS to its cognate
TLR receptors, subsequently selecting how to affect down-
stream host immune signalling. Interestingly, a second
type of LPS has also been identified in P. gingivalis, con-
taining a distinct anionic polysaccharide linked to lipid A,
known as A-LPS (Paramonov et al., 2005). A-LPS is
required for cell integrity and serum resistance (Shoji
et al., 2002; Paramonov et al., 2005; Slaney et al., 2006)
and is structurally associated with the Arg-X gingipain
(Curtis et al., 1999; Paramonov et al., 2005). It is also a
weaker inducer of cytokine responses by human mono-
cytes, as compared with the conventional LPS (Rangarajan
et al., 2008). Collectively, the modifications and heteroge-
neity of P. gingivalis LPS can result in opposing actions
and immunological deregulation. Strategically, this is in
line with the manipulation of host innate immune
responses by this species, to facilitate its adaptation and
survival into the host.
The CPS of P. gingivalis
A major virulence factor of P. gingivalis is considered to
be its capsule, also known as CPS or K-antigen (Schifferle
et al., 1989; Holt et al., 1999; Farquharson et al., 2000;
Aduse-Opoku et al., 2006; Brunner et al., 2010a, b).
Based on the capacity of CPS to generate systemic IgG
antibody responses, at least six different serotypes have
been identified (Laine et al., 1997; Sims et al., 2001).
Encapsulated P. gingivalis strains are shown to be highly
invasive, causing spreading infection in a murine lesion
model, whereas nonencapsulated strains induced only
localized abscesses (Laine & van Winkelhoff, 1998). Inter-
estingly, immunization with P. gingivalis CPS induced a
high IgG systemic response (Choi et al., 1998) and
reduced P. gingivalis-induced alveolar bone loss (Gonzalez
et al., 2003). Encapsulated strains of P. gingivalis are
more resistant to phagocytosis by polymorphonuclear leu-
kocytes than nonencapsulated strains (Sundqvist et al.,
1991) and have differential capacities to adhere to gingi-
val epithelial cells (Dierickx et al., 2003). Moreover, dif-
ferences in CPS serotypes can reflect differential capacities
in chemokine stimulation by macrophages (d’Empaire
et al., 2006) or cytokine stimulation by dendritic cells
(Vernal et al., 2009). Interestingly, a nonencapsulated
P. gingivalis knockout mutant strain was found to be a
more potent inducer of cytokine synthesis by human gin-
gival fibroblasts, as compared with the corresponding
wild-type strain, implying a role of CPS in downplaying
the innate immune responses (Brunner et al., 2010a, b).
Although it is evident that the presence of CPS, or its
individual serotypes, could be determinants of the viru-
lence of P. gingivalis, the potential involvement of this
antigen in the overall deregulation of host responses
awaits further clarification.
The fimbriae of P. gingivalis
The fimbriae of P. gingivalis are thin, filamentous cell-
surface protrusions that facilitate its adherence to salivary
proteins, extracellular matrix, eukaryotic cells and bacteria
of either the same or other species. Through its fimbriae,
P. gingivalis can thus attach to early colonizing bacteria,
and participate in the developing biofilm structure. Type
I (major) fimbriae have important roles in colonization
and invasion, whereas type II (minor) fimbriae possess a
higher proinflammatory capacity (Lamont & Jenkinson,
1998; Amano et al., 2004; Hajishengallis et al., 2008).
Interestingly, however, P. gingivalis strains W50 and W83
that lack major fimbriae are still invasive, as
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demonstrated in experimental subcutaneous abscess mod-
els (Inaba et al., 2008). A particular role of fimbriae is
revealed in the induction of bone destruction in experi-
mental periodontitis models. To this extent, infection of
rats with nonfimbriated P. gingivalis strains exhibited
reduced periodontal bone loss, compared with infection
with fimbriated strains (Jotwani & Cutler, 2004). More-
over, immunization against P. gingivalis fimbriae pro-
tected against bone loss in gnothobiotic rats (Malek et al.,
1994; Sharma et al., 2001). Other properties of both major
and minor fimbriae are the induction of proinflammatory
cytokines and production of matrix metalloproteinases
(MMPs), such as IL-1, IL-6, IL-8, TNF-a and MMP-9, by
various host cells (Jotwani et al., 2010; Ogawa et al., 1994;
Pollreisz et al., 2010; Takahashi et al., 2006).
Porphyromonas gingivalis fimbriae can signal through
either TLR2 or TLR4. Activation of TLR2 by fimbriae results
in a differential signalling pattern compared with activation
by P. gingivalis LPS (Hajishengallis et al., 2006). Fimbriae
can directly induce two distinct signalling pathways, one
that mediates production of proinflammatory cytokines,
such as IL-6 and TNF-a, and another that mediates the
expression of cell adhesion molecules, such as ICAM-1 (Ha-
jishengallis et al., 2009). On the other hand, signalling
through TLR4 requires an additional costimulation of CD14
and MD-2 (Davey et al., 2008). Interestingly, major fimb-
riae can exploit TLR2 signalling in order to interact with
complement receptor 3 (CR3), in a novel ‘inside-out’ signal-
ling pattern (Hajishengallis et al., 2007; Wang et al., 2007).
This interaction activates the binding capacity of CR3 and
allows for internalization of P. gingivalis in macrophages
and reduction of IL-12 production, which may collectively
inhibit bacterial clearance (Hajishengallis et al., 2007).
The gingipains of P. gingivalis
Gingipains are a group of cell surface cysteine proteinases
of P. gingivalis that can also be present in secreted soluble
form. They account for 85% of the total proteolytic activ-
ity of P. gingivalis (Potempa et al., 1997). Based on their
substrate specificity, they are divided into arginine-
specific (Arg-X) and lysine-specific (Lys-X) gingipains
(Curtis et al., 2001; Guo et al., 2010). Arg-X gingipains
have trypsin-like activity, and can degrade extracellular
matrix components, including the integrin–fibronectin-
binding, cytokine, immunoglobulin and complement fac-
tors. There are two types of Arg-X gingipains, namely
RgpA, which contains a proteolytic and an adhesion
domain, and RgpB, which contains only the proteolytic
domain. There is one type of Lys-X gingipain, Kgp, which
contains both a proteolytic and an adhesion domain.
There are sequence similarities between the adhesion
domains of Kgp and RgpA (Curtis et al., 2001).
The gingipains have multiple effects on the molecular
components of the immune response, and as such they
can deregulate these responses. For instance, they can
cleave several T-cell receptors, such as CD2, CD4 and
CD8 (Kitamura et al., 2002), thereby hampering the cell-
mediated immune response. They can also stimulate
expression of protease-activated receptors in neutrophils
(Lourbakos et al., 1998), gingival epithelial cells (Lourba-
kos et al., 2001), gingival fibroblasts and T cells (Belibasa-
kis et al., 2010), which are crucial for the induction of
cytokine responses and the establishment of chronic
inflammation in periodontitis (Holzhausen et al., 2010;
Fagundes et al., 2011). Gingipains can also stimulate IL-6
production by oral epithelial cells (Lourbakos et al.,
2001) and IL-8 production by gingival fibroblasts (Oido-
Mori et al., 2001), enhancing the inflammatory responses.
However, they can also proteolytically inactivate both
anti-inflammatory (IL-4, IL-5) and pro-inflammatory
(IL-12, IFN-c) cytokines (Yun et al., 1999, 2001, 2002;
Tam et al., 2009).
A number of particularly interesting effects are exerted
by the gingipains on components of the complement sys-
tem. Arg-X gingipains can cleave the C5 molecule, resulting
in release of its C5a component, which is crucial for
enhancing the recruitment of PMNs (Wingrove et al.,
1992; Imamura et al., 2001). On the other hand, Lys-X can
inactivate the C5a receptor on PMNs, an action that may
actually impair their recruitment (Jagels et al., 1996a, b).
Along this line, the Arg-X gingipains can degrade the C3
molecule, potentially contributing to decreased bacterial
opsonization (Schenkein et al., 1995). This property could
confer increased resistance of P. gingivalis to bactericidal
activity.
Apart from their effect on immune responses, gingipains
mayalsobeinvolvedinthebindingofP. gingivalis tohostcells,
asRgp–Kgpcomplexeshavebeenshowntomediateadherence
ongingivalepithelialcellsandgingivalfibroblasts(Chenet al.,
2001;Grenier et al., 2003;Andrian et al., 2004). Interestingly,
when P. gingivalis intracellularly invades gingival epithelial
cells, expression of gingipain is downregulated (Xia et al.,
2007).
Gingipains may also affect vascular permeability and
bleeding at the periodontal site. They can proteolytically
activate plasma kallikrein and bradykinin, or alternatively
increase the release of thrombin and prothrombin, which
can result in increased vascular permeability and PMN
influx (Imamura et al., 1994, 1995a). Moreover, by degrad-
ing fibrinogen (Scott et al., 1993), they may contribute to
inhibition of blood coagulation and increase bleeding at the
site (Imamura et al., 1995b) , thus enhancing the availability
of hemin required for P. gingivalis growth.
Collectively, studies in various experimental systems
indicate that gingipains have seemingly contradicting
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actions on the innate immune responses, hampering
interpretation of their role in the pathogenesis of peri-
odontitis. Nevertheless, such differences may be recon-
ciled by the existence of a concentration gradient of
gingipains in the tissue (Pathirana et al., 2010). Closer to
the gingival epithelial barrier where the biofilm resides,
gingipain concentrations are high, causing degradation or
deregulation of various components of the immune
response. This hampers bacterial clearance and facilitates
bacterial invasion. Nevertheless, deeper into the gingival
connective tissue, gingipain concentrations become gradu-
ally lower and stimulate, rather than inhibit, inflamma-
tion. This may in turn induce connective tissue and bone
destruction, which are the hallmarks of periodontitis.
Conclusions
It is evident that P. gingivalis has developed mechanisms
to invade and persist into the host, by astutely adapting
to its local niche. Its paradoxically opposing (stimulatory
vs. inhibiting) effects on innate immune and inflamma-
tory responses aim to subvert host defence mechanisms,
in order to facilitate its survival in the tissues (Hajishen-
gallis, 2009; Hajishengallis & Lambris, 2011). The net
effect of this deregulated equilibrium is likely to deter-
mine if site-specific disease progresses beyond or remains
at stationary phase. Whether inflammation is beneficial
for P. gingivalis may depend on the stage of its establish-
ment in the host (Hajishengallis, 2009; Pathirana et al.,
2010). At early stages, suppression of inflammation and
evasion of host recognition would aid P. gingivalis in col-
onizing, invading and establishing at the targeted site. At
later stages, once P. gingivalis is well established, inducing
inflammation may facilitate its increased demands in
nutrients. Alternatively, P. gingivalis may induce a ‘non-
productive inflammation’, one that fails to eliminate it,
yet is sufficient to induce mediators of tissue destruction
(Hajishengallis, 2009).
Finally, as periodontitis is of polymicrobial nature, it is
reasonable to consider the role of different bacterial spe-
cies within the context of (subgingival) biofilm communi-
ties. Hence, P. gingivalis is likely to function in concerted
action with other species, to their mutual benefit. For
instance, complement manipulation by P. gingivalis may
denote a coevolution strategy to support other species
present in the biofilm, which may reciprocally provide
further colonization opportunities and nutrient availability
to P. gingivalis. Subsequent changes in the local microen-
vironment can differentially regulate expression of its
virulence factors, and hence the proinflammatory or
anti-inflammatory potentials of P. gingivalis. This is
strongly indicated by recent evidence demonstrating that
even at low abundance, this species qualitatively and
quantitatively affects the composition of the oral commen-
sal microbiota, which are in turn required for P. gingiva-
lis-induced inflammatory bone loss (Hajishengallis et al.,
2011). For these reasons, P. gingivalis is now considered a
‘keystone’ species in subgingival biofilms (Honda, 2011).
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